To scroll text in this page

Global Navigation
Global Navigation end

About Astellas

Start of the main text

2018 News Releases

About RSS

Astellas Receives Orphan Designation from the European Commission for Gilteritinib for the Treatment of Acute Myeloid Leukaemia (pdf 377KB)

January 23, 2018

Printer-friendly version

Main Text end
Local Navigation
Local Navigation end
Related Links